People weaning themselves from painkillers may soon get a helping hand via a zap in the brain. The FDA says the snappy-sounding Neuro-Stim System Bridge, which costs between $600 and $800, can now be marketed as a way to treat opioid withdrawal.
It’s a seemingly simple device, which attaches to the skin behind the ear and uses a chip to stimulate part of the brain that usually processes pain information such as that created by withdrawal. While it’s been used in clinics to treat withdrawal in the past, until now it was approved by the FDA only for treatment of acute and chronic pain—not symptoms related to halting opioid consumption.
As Stat points out, the evidence supporting the device’s efficacy is slim: the FDA cites just a single study including 73 patients. But that series of experiments did show that 88 percent of them “successfully transitioned” away from opioids after using the device for five days. And at any rate, it’s a start against an overpowering scourge.
More solutions may be forthcoming. As we’ve reported, devices like the Bridge are just one of a series of promising approaches to beating addictive drugs—and in the meantime, the quest for painkillers that aren’t addictive continues, too.
It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.
If they ever hit our roads for real, other drivers need to know exactly what they are.
Maximize business value with data-driven strategies
Every organization is now collecting data, but few are truly data driven. Here are five ways data can transform your business.
Cryptocurrency fuels new business opportunities
As adoption of digital assets accelerates, companies are investing in innovative products and services.
Where to get abortion pills and how to use them
New US restrictions could turn abortion into do-it-yourself medicine, but there might be legal risks.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.